Cellular Therapy
News
New drug approved for hepatic veno-occlusive disease
Conference Coverage
Children who have stem cell transplants need skin exams, sun protection
Key clinical point: Children who have had a hematopoietic stem cell transplant need to have routine skin exams and be educated about sun...
News
New drug comparable to voriconazole for aspergillosis
Key clinical point: Isavuconazole is an appropriate alternative for primary treatment of suspected invasive aspergillosis. Major finding: All-...
News
Resources limit availability of bone marrow transplants
Key clinical point: In regions with limited resources, peripheral blood stem cells were used more frequently than bone marrow in hematopoietic...
News
Medicare to cover HSCT in approved clinical trials for myeloma, myelofibrosis, sickle cell disease
News
CAR T-cells induce remissions, avoid GVHD in relapsed B-cell malignancies
Key clinical point: In patients who relapsed after allogeneic hematopoietic stem-cell transplantation, anti-CD19 chimeric antigen receptor (CAR) T...
Conference Coverage
VIDEO: RBCs have extended shelf life, randomized trial shows
Conference Coverage
ASH: Gene therapy eases effects of rare Wiskott-Aldrich syndrome
Key clinical point: Gene therapy might safely and effectively correct an inherited immunodeficiency syndrome. Major finding: Six of eight...
Conference Coverage
Big declines seen in aspergillosis mortality
The outlook for patients with aspergillosis-related hospitalization improved greatly during a recent 10-year period.
News
Excellent survival after ASCT for light-chain amyloidosis
Key clinical point: Early mortality after autologous hematopoietic stem cell transplantation for light-chain amyloidosis has declined dramatically...
News
CTL019 induced a durable complete response in refractory MM
Key clinical point: CTL019 cell therapy after stem cell transplant led to a durable complete response that persisted at 12 months in a patient...